Clinical trial
An Open Non Comparative Multicenter Prospective Study to Evaluate Efficacy and Safety of Macrolane VRF20 in Treatment of Pectus Excavatum
NCT01750112 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Non Comparative Multicenter Prospective Study to Evaluate Efficacy and Safety of Macrolane VRF20 in Treatment of Pectus Excavatum
- Lead sponsor
- Galderma R&D
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2012
- Completion date
- September 30, 2016
- Enrollment
- 23 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
pectus excavatum deformity